PAD Flashcards
COX inhibitor
Aspirin
Aspirin MOA
- Nonselective irreversible COX inhibitor
2. Reduces platelet production of TXA2
Aspirin PK
- Antithrombotic (blocks TXA2)@ low dose (81-325 mg)
2. IRREVERSIBLE, 7-10 day lifespan
Aspirin side effects
GI upset and/or bleeding
Aspirin contraindications
- Active bleeding
- Hemophilia
- Thrombocytopenia
Dipyridamole (Aggrenox) MOA
- Phosphodiesterase inhibitor
2. Platelet aggregation inhibitor
Dipyridamole (Aggrenox) clinical application
Combine with ASA
Dipyridamole (Aggrenox) side effects
- HA
- Hypotension
- Dizziness
- Angina
Dipyridamole (Aggrenox) contraindications
- Active bleeding
2. CAD
Cilostazol (pletal) contraindications
CHF patients
=decreased survival
Cilostazol (pletal) MOA
- PDE inhibitor
- Suppress platelet aggregation
- Direct arter vasodilator
Clopidogrel (Plavix) MOA
Inhibits binding of ADP to its platelet receptor= IRREVERSIBLE inhibition of platelets
Clopidogrel (Plavix) clinical application
- ACS
- Prevention of responses after stent/angiography
- Prevent arterial thrombosis
What was the first drug used for PAD?
Pentoxifylline (trental)
Pentoxifylline (trental) MOA
RBCs flexibility-allows for easier flow through narrowed vessels